β-Lactamase-IN-5

• UNSPSC Description:

  β-Lactamase-IN-5 is a β-lactamase inhibitor extracted from patent WO2013149121A1, compound 720. β-Lactamase-IN-5 can be used for the research of bacterial infections[1].

• Target Antigen:

  Bacterial; Beta-lactamase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/β-lactamase-in-5.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1[N@]2[C@@](C3=NN=C(CCCN)O3)([H])CC[C@@H](N1OS(=O)(O)=O)C2

• Molecular Weight:

  347.35

• References & Citations:

  [1]Gu YG, et, al. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors. WO2013149121A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1463521-39-2